Nobuhiko Mizuno

C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy

M. Yao, K. Makiyama, Y. Kubota, 2012, BMC Cancer.

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

M. Yao, K. Makiyama, H. Miyamoto, 2016, BioMed research international.

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas

Y. Nagashima, M. Yao, K. Makiyama, 2014, Cancer medicine.

Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma

Y. Miyagi, T. Sasada, T. Yokose, 2020, Cancer Immunology, Immunotherapy.